PROTAC: an effective targeted protein degradation strategy for cancer therapy

SM Qi, J Dong, ZY Xu, XD Cheng, WD Zhang… - Frontiers in …, 2021‏ - frontiersin.org
Proteolysis targeting chimeric (PROTAC) technology is an effective endogenous protein
degradation tool developed in recent years that can ubiquitinate the target proteins through …

[HTML][HTML] A comprehensive analysis and anti-cancer activities of quercetin in ROS-mediated cancer and cancer stem cells

P Biswas, D Dey, PK Biswas, TI Rahaman… - International journal of …, 2022‏ - mdpi.com
Reactive oxygen species (ROS) induce carcinogenesis by causing genetic mutations,
activating oncogenes, and increasing oxidative stress, all of which affect cell proliferation …

[HTML][HTML] Therapeutics targeting p53-MDM2 interaction to induce cancer cell death

N Koo, AK Sharma, S Narayan - International journal of molecular …, 2022‏ - mdpi.com
Named as the guardian of the genome, p53 is a tumor suppressor that regulates cell
function, often through many different mechanisms such as DNA repair, apoptosis, cell cycle …

Medicinal chemistry strategies to discover P-glycoprotein inhibitors: An update

J Dong, Z Qin, WD Zhang, G Cheng, AG Yehuda… - Drug Resistance …, 2020‏ - Elsevier
The presence of multidrug resistance (MDR) in malignant tumors is one of the primary
causes of treatment failure in cancer chemotherapy. The overexpression of the ATP binding …

Ferroptosis‐modulating small molecules for targeting drug‐resistant cancer: Challenges and opportunities in manipulating redox signaling

SC Koeberle, AP Kipp, H Stuppner… - Medicinal Research …, 2023‏ - Wiley Online Library
Ferroptosis is an iron‐dependent cell death program that is characterized by excessive lipid
peroxidation. Triggering ferroptosis has been proposed as a promising strategy to fight …

Creating and screening natural product libraries

BAP Wilson, CC Thornburg, CJ Henrich… - Natural product …, 2020‏ - pubs.rsc.org
Covering: up to 2020 The National Cancer Institute of the United States (NCI) has initiated a
Cancer Moonshot program entitled the NCI Program for Natural Product Discovery. As part …

The efficacy of natural bioactive compounds against prostate cancer: Molecular targets and synergistic activities

MAR Mia, D Dey, MR Sakib, MY Biswas… - Phytotherapy …, 2023‏ - Wiley Online Library
Globally, prostate cancer (PCa) is regarded as a challenging health issue, and the number
of PCa patients continues to rise despite the availability of effective treatments in recent …

Remodeling tumor microenvironment with natural products to overcome drug resistance

W Zhang, S Li, C Li, T Li, Y Huang - Frontiers in immunology, 2022‏ - frontiersin.org
With cancer incidence rates continuing to increase and occurrence of resistance in drug
treatment, there is a pressing demand to find safer and more effective anticancer strategy for …

Targeting USP7-mediated deubiquitination of MDM2/MDMX-p53 pathway for cancer therapy: are we there yet?

SM Qi, G Cheng, XD Cheng, Z Xu, B Xu… - Frontiers in cell and …, 2020‏ - frontiersin.org
The p53 tumor suppressor protein and its major negative regulators MDM2 and MDMX
oncoproteins form the MDM2/MDMX-p53 circuitry, which plays critical roles in regulating …

p53 modulation of autophagy signaling in cancer therapies: perspectives mechanism and therapeutic targets

MA Rahman, MN Park, MDH Rahman… - Frontiers in cell and …, 2022‏ - frontiersin.org
The key tumor suppressor protein p53, additionally known as p53, represents an attractive
target for the development and management of anti-cancer therapies. p53 has been …